The influence of Elixhauser comorbidity index on percutaneous coronary intervention outcomes.
Jessica PottsVinayak NagarajaJassim Al SuwaidiSalvatore BrugalettaSara C MartinezMohamed Chadi AlraiesDavid L FischmanChun Shing KwokJim NolanDarren MylotteMamas A MamasPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
Our study of over six million PCI procedures demonstrates that patients with the greatest comorbid burden (as defined by an ECS of >13) have a fivefold increase risk of in-hospital mortality, a fourfold increase in in-hospital periprocedural complications and an 11-fold increase in major bleeding events once differences in baseline patient characteristics are adjusted for. In addition, ECS significantly impacts the length of stay and doubles the healthcare costs. Comorbid burden is an important predictor of poor outcomes after PCI and should be considered as part of the decision-making processes in patients undergoing PCI.
Keyphrases
- percutaneous coronary intervention
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute coronary syndrome
- acute myocardial infarction
- antiplatelet therapy
- coronary artery disease
- healthcare
- coronary artery bypass grafting
- atrial fibrillation
- patients undergoing
- decision making
- risk factors
- coronary artery bypass
- case report
- heart failure
- type diabetes
- emergency department
- venous thromboembolism
- direct oral anticoagulants
- acute care
- electronic health record
- insulin resistance
- skeletal muscle
- weight loss